Advertisement

Nanorobots Deliver

DNA aptamers are short strands that have high binding affinity for a target protein that can be used as triggers for releasing cargo from delivery vehicles. Douglas et al. (p. 831) used this strategy to design DNA origami “nanorobots”—complex shaped structures created by manipulating a long DNA strand through binding with shorter “staple” strands—that could deliver payloads such as gold nanoparticles or fluorescently labeled antibody fragments. These nanorobots were designed to open in response to specific cell-surface proteins, releasing molecules that triggered cell signaling.

Abstract

We describe an autonomous DNA nanorobot capable of transporting molecular payloads to cells, sensing cell surface inputs for conditional, triggered activation, and reconfiguring its structure for payload delivery. The device can be loaded with a variety of materials in a highly organized fashion and is controlled by an aptamer-encoded logic gate, enabling it to respond to a wide array of cues. We implemented several different logical AND gates and demonstrate their efficacy in selective regulation of nanorobot function. As a proof of principle, nanorobots loaded with combinations of antibody fragments were used in two different types of cell-signaling stimulation in tissue culture. Our prototype could inspire new designs with different selectivities and biologically active payloads for cell-targeting tasks.

Get full access to this article

View all available purchase options and get full access to this article.

Supplementary Material

File (douglas.som-corrected.pdf)

References and Notes

1
Rothemund P. W. K., Folding DNA to create nanoscale shapes and patterns. Nature 440, 297 (2006).
2
Ke Y., et al., Scaffolded DNA origami of a DNA tetrahedron molecular container. Nano Lett. 9, 2445 (2009).
3
Douglas S. M., et al., Self-assembly of DNA into nanoscale three-dimensional shapes. Nature 459, 414 (2009).
4
Dietz H., Douglas S. M., Shih W. M., Folding DNA into twisted and curved nanoscale shapes. Science 325, 725 (2009).
5
Kuzuya A., et al., Precisely programmed and robust 2D streptavidin nanoarrays by using periodical nanometer-scale wells embedded in DNA origami assembly. ChemBioChem 10, 1811 (2009).
6
Voigt N. V., et al., Single-molecule chemical reactions on DNA origami. Nat. Nanotechnol. 5, 200 (2010).
7
Stephanopoulos N., et al., Immobilization and one-dimensional arrangement of virus capsids with nanoscale precision using DNA origami. Nano Lett. 10, 2714 (2010).
8
Stojanovic M. N., Stefanovic D., A deoxyribozyme-based molecular automaton. Nat. Biotechnol. 21, 1069 (2003).
9
Seelig G., Soloveichik D., Zhang D. Y., Winfree E., Enzyme-free nucleic acid logic circuits. Science 314, 1585 (2006).
10
Benenson Y., Gil B., Ben-Dor U., Adar R., Shapiro E., An autonomous molecular computer for logical control of gene expression. Nature 429, 423 (2004).
11
Ding B., Seeman N. C., Operation of a DNA robot arm inserted into a 2D DNA crystalline substrate. Science 314, 1583 (2006).
12
Andersen E. S., et al., Self-assembly of a nanoscale DNA box with a controllable lid. Nature 459, 73 (2009).
13
Douglas S. M., et al., Rapid prototyping of 3D DNA-origami shapes with caDNAno. Nucleic Acids Res. 37, 5001 (2009).
14
See supporting material on Science Online.
15
Hamaguchi N., Ellington A., Stanton M., Aptamer beacons for the direct detection of proteins. Anal. Biochem. 294, 126 (2001).
16
Nutiu R., Li Y., Structure-switching signaling aptamers. J. Am. Chem. Soc. 125, 4771 (2003).
17
Boniface J. J., et al., Initiation of signal transduction through the T cell receptor requires the multivalent engagement of peptide/MHC ligands. Immunity 9, 459 (1998).
18
Alivisatos A. P., et al., Organization of ‘nanocrystal molecules’ using DNA. Nature 382, 609 (1996).
19
Yurke B., Turberfield A. J., Mills A. P., Simmel F. C., Neumann J. L., A DNA-fuelled molecular machine made of DNA. Nature 406, 605 (2000).
20
Green L. S., et al., Inhibitory DNA ligands to platelet-derived growth factor B-chain. Biochemistry 35, 14413 (1996).
21
Tang Z., et al., Selection of aptamers for molecular recognition and characterization of cancer cells. Anal. Chem. 79, 4900 (2007).
22
Huang Y. F., et al., Molecular assembly of an aptamer-drug conjugate for targeted drug delivery to tumor cells. ChemBioChem 10, 862 (2009).
23
Robertson M. J., et al., Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia. Exp. Hematol. 24, 406 (1996).
24
Vitale C., et al., Surface expression and function of p75/AIRM-1 or CD33 in acute myeloid leukemias: Engagement of CD33 induces apoptosis of leukemic cells. Proc. Natl. Acad. Sci. U.S.A. 98, 5764 (2001).
25
Ye Z., Lee C. M. L., Sun G. W., Gan Y. H., Burkholderia pseudomallei infection of T cells leads to T-cell costimulation partially provided by flagellin. Infect. Immun. 76, 2541 (2008).

(0)eLetters

eLetters is a forum for ongoing peer review. eLetters are not edited, proofread, or indexed, but they are screened. eLetters should provide substantive and scholarly commentary on the article. Embedded figures cannot be submitted, and we discourage the use of figures within eLetters in general. If a figure is essential, please include a link to the figure within the text of the eLetter. Please read our Terms of Service before submitting an eLetter.

Log In to Submit a Response

No eLetters have been published for this article yet.

Information & Authors

Information

Published In

Science
Volume 335 | Issue 6070
17 February 2012

Submission history

Received: 16 September 2011
Accepted: 12 January 2012
Published in print: 17 February 2012

Permissions

Request permissions for this article.

Acknowledgments

We thank J. Ritz for providing NKL cells; C. Reynolds for technical assistance with NKL cells; C. Strong and G. McGill for assistance with 3D visualization using Molecular Maya; A. Marblestone for helpful discussions; and J. Markson for comments on the manuscript. S.M.D. holds a Career Award at the Scientific Interface from the Burroughs Wellcome Fund and a Wyss Technology Development Fellowship, and I.B. is supported by a fellowship from the Life Sciences Research Foundation. S.M.D. and I.B. designed and performed the experiments and analyzed the data; S.M.D., I.B., and G.M.C. wrote the manuscript.

Authors

Affiliations

Shawn M. Douglas*
Wyss Institute for Biologically Inspired Engineering and Department of Genetics, Harvard Medical School, Boston, MA 02115, USA.
Ido Bachelet*
Wyss Institute for Biologically Inspired Engineering and Department of Genetics, Harvard Medical School, Boston, MA 02115, USA.
George M. Church
Wyss Institute for Biologically Inspired Engineering and Department of Genetics, Harvard Medical School, Boston, MA 02115, USA.

Notes

*
These authors contributed equally to this work.
To whom correspondence should be addressed. E-mail: http://arep.med.harvard.edu/gmc/email.html

Metrics & Citations

Metrics

Article Usage

Altmetrics

Citations

Cite as

Export citation

Select the format you want to export the citation of this publication.

Cited by

  1. An RNA origami robot that traps and releases a fluorescent aptamer, Science Advances, 10, 12, (2024)./doi/10.1126/sciadv.adk1250
    Abstract
  2. Nanoparticles as Drug Delivery Systems: A Review of the Implication of Nanoparticles’ Physicochemical Properties on Responses in Biological Systems, Polymers, 15, 7, (1596), (2023).https://doi.org/10.3390/polym15071596
    Crossref
  3. Enhancing the Effectiveness of Oligonucleotide Therapeutics Using Cell-Penetrating Peptide Conjugation, Chemical Modification, and Carrier-Based Delivery Strategies, Pharmaceutics, 15, 4, (1130), (2023).https://doi.org/10.3390/pharmaceutics15041130
    Crossref
  4. Controlled Assembly of Fluorophores inside a Nanoliposome, Molecules, 28, 2, (911), (2023).https://doi.org/10.3390/molecules28020911
    Crossref
  5. DNA-Based Nanomaterials as Drug Delivery Platforms for Increasing the Effect of Drugs in Tumors, Cancers, 15, 7, (2151), (2023).https://doi.org/10.3390/cancers15072151
    Crossref
  6. Nanoconstructs for theranostic application in cancer: Challenges and strategies to enhance the delivery, Frontiers in Pharmacology, 14, (2023).https://doi.org/10.3389/fphar.2023.1101320
    Crossref
  7. DNA Nanobots – Emerging Customized Nanomedicine in Oncology, Current Drug Delivery, 20, 2, (111-126), (2023).https://doi.org/10.2174/1567201819666220331094812
    Crossref
  8. undefined, 37th IEEE/ACM International Conference on Automated Software Engineering, (1-5), (2023).https://doi.org/10.1145/3551349.3559562
    Crossref
  9. Reconfigurable self-assembled DNA devices, Science Robotics, 8, 77, (2023)./doi/10.1126/scirobotics.adh8148
    Abstract
  10. Modular reconfiguration of DNA origami assemblies using tile displacement, Science Robotics, 8, 77, (2023)./doi/10.1126/scirobotics.adf1511
    Abstract
  11. See more
Loading...

View Options

Check Access

Log in to view the full text

AAAS ID LOGIN

AAAS login provides access to Science for AAAS Members, and access to other journals in the Science family to users who have purchased individual subscriptions.

Log in via OpenAthens.
Log in via Shibboleth.

More options

Register for free to read this article

As a service to the community, this article is available for free. Login or register for free to read this article.

Purchase this issue in print

Buy a single issue of Science for just $15 USD.

View options

PDF format

Download this article as a PDF file

Download PDF

Full Text

FULL TEXT

Media

Figures

Multimedia

Tables

Share

Share

Share article link

Share on social media